Cheung AN[au] - Search Results

Year	Number of Results
1991	1
1992	3
1993	7
1994	7
1995	2
1996	4
1997	3
1998	7
1999	12
2000	4
2001	11
2002	9
2003	15
2004	11
2005	14
2006	15
2007	7
2008	18
2009	15
2010	11
2011	18
2012	10
2013	8
2014	9
2015	10
2016	5
2017	5
2018	14
2019	11
2020	10
2021	7
2022	4

1

Strategic Combination Therapies for Ovarian Cancer.

Li X, Ng ASN, Mak VCY, Chan KKL, Cheung ANY, Cheung LWT. Li X, et al. Among authors: cheung any. Curr Cancer Drug Targets. 2020;20(8):573-585. doi: 10.2174/1568009620666200511084007. Curr Cancer Drug Targets. 2020. PMID: 32392113 Review.

2

The Lancet Commission on diagnostics: transforming access to diagnostics.

Fleming KA, Horton S, Wilson ML, Atun R, DeStigter K, Flanigan J, Sayed S, Adam P, Aguilar B, Andronikou S, Boehme C, Cherniak W, Cheung AN, Dahn B, Donoso-Bach L, Douglas T, Garcia P, Hussain S, Iyer HS, Kohli M, Labrique AB, Looi LM, Meara JG, Nkengasong J, Pai M, Pool KL, Ramaiya K, Schroeder L, Shah D, Sullivan R, Tan BS, Walia K. Fleming KA, et al. Among authors: cheung an. Lancet. 2021 Nov 27;398(10315):1997-2050. doi: 10.1016/S0140-6736(21)00673-5. Epub 2021 Oct 6. Lancet. 2021. PMID: 34626542 Free PMC article. Review. No abstract available.

3

Targeting DNA Damage Response Pathway in Ovarian Clear Cell Carcinoma.

Wong OGW, Li J, Cheung ANY. Wong OGW, et al. Among authors: cheung any. Front Oncol. 2021 Oct 19;11:666815. doi: 10.3389/fonc.2021.666815. eCollection 2021. Front Oncol. 2021. PMID: 34737943 Free PMC article. Review.

4

Dysregulated stemness-related genes in gynecological malignancies.

Mak VC, Siu MK, Wong OG, Chan KK, Ngan HY, Cheung AN. Mak VC, et al. Among authors: cheung an. Histol Histopathol. 2012 Sep;27(9):1121-30. doi: 10.14670/HH-27.1121. Histol Histopathol. 2012. PMID: 22806899 Review.

5

Endometrial stromal sarcoma of uterus.

Xue WC, Cheung AN. Xue WC, et al. Among authors: cheung an. Best Pract Res Clin Obstet Gynaecol. 2011 Dec;25(6):719-32. doi: 10.1016/j.bpobgyn.2011.07.004. Epub 2011 Aug 6. Best Pract Res Clin Obstet Gynaecol. 2011. PMID: 21820965 Review.

6

p85β regulates autophagic degradation of AXL to activate oncogenic signaling.

Rao L, Mak VCY, Zhou Y, Zhang D, Li X, Fung CCY, Sharma R, Gu C, Lu Y, Tipoe GL, Cheung ANY, Mills GB, Cheung LWT. Rao L, et al. Among authors: cheung any. Nat Commun. 2020 May 8;11(1):2291. doi: 10.1038/s41467-020-16061-7. Nat Commun. 2020. PMID: 32385243 Free PMC article.

7

SENP1-mediated deSUMOylation of JAK2 regulates its kinase activity and platinum drug resistance.

Li J, Wu R, Yung MMH, Sun J, Li Z, Yang H, Zhang Y, Liu SS, Cheung ANY, Ngan HYS, Braisted JC, Zheng W, Wei H, Gao Y, Nemes P, Pei H, Chan DW, Li Y, Zhu W. Li J, et al. Among authors: cheung any. Cell Death Dis. 2021 Apr 1;12(4):341. doi: 10.1038/s41419-021-03635-6. Cell Death Dis. 2021. PMID: 33795649 Free PMC article.

8

Molecular targets in gynaecological cancers.

Cheung AN. Cheung AN. Pathology. 2007 Feb;39(1):26-45. doi: 10.1080/00313020601153273. Pathology. 2007. PMID: 17365821 Review.

9

Pathology of gestational trophoblastic diseases.

Cheung AN. Cheung AN. Best Pract Res Clin Obstet Gynaecol. 2003 Dec;17(6):849-68. doi: 10.1016/s1521-6934(03)00094-4. Best Pract Res Clin Obstet Gynaecol. 2003. PMID: 14614885 Review.

10

TrkB as a therapeutic target for ovarian cancer.

Siu MK, Wong OG, Cheung AN. Siu MK, et al. Among authors: cheung an. Expert Opin Ther Targets. 2009 Oct;13(10):1169-78. doi: 10.1517/14728220903196787. Expert Opin Ther Targets. 2009. PMID: 19694498 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results